Seaport Therapeutics, Inc. (SPTX)
19.98
-0.15
(-0.75%)
USD |
NASDAQ |
Nov 13, 16:00
19.93
-0.05
(-0.25%)
After-Hours: 19:59
Seaport Therapeutics Total Liabilities (Quarterly) : 20.17M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 20.17M |
| June 30, 2026 | 19.08M |
| Date | Value |
|---|---|
| March 31, 2026 | 17.97M |
| December 31, 2025 | 16.23M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 115.90B |
| Bristol Myers Squibb Co. | 65.37B |
| Harmony Biosciences Holdings, Inc. | 406.01M |
| ANI Pharmaceuticals, Inc. | 930.55M |
| Corcept Therapeutics, Inc. | 200.29M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 417.62M |
| Shareholders Equity (Quarterly) | 397.46M |
| Debt to Equity Ratio | 0.0118 |
| Current Ratio | 17.48 |
| Net Debt Paydown Yield | -0.09% |